Presentation Three-Year Clinical and Multimodality Imaging Results of the ABSORB Trial Presenter: 53632|Koen Nieman August 07, 2013 REGISTER for free or LOG IN to view this content DES/BRS/DCB CT/CT-FFR Factoid Up Next Presentation Higher Persistence in Newly Diagnosed Nonvalvular A-fib Patients Treated with Dabigatran vs. Warfarin Presenter: M. Zalesak August 12, 2013 More slides + Presentation Clinical Outcomes of 5,358 Patients Undergoing Direct Open Bypass or Endovascular Treatment for Aortoiliac Occlusive Disease Presenter: Jeffrey E. Indes August 13, 2013 Presentation SOLACI 2013 Why Has FFR Been Considered the Default Strategy to Guide PCI? Presenter: Daniel Chami? July 24, 2013 We Recommend
Presentation Higher Persistence in Newly Diagnosed Nonvalvular A-fib Patients Treated with Dabigatran vs. Warfarin Presenter: M. Zalesak August 12, 2013
Presentation Clinical Outcomes of 5,358 Patients Undergoing Direct Open Bypass or Endovascular Treatment for Aortoiliac Occlusive Disease Presenter: Jeffrey E. Indes August 13, 2013
Presentation SOLACI 2013 Why Has FFR Been Considered the Default Strategy to Guide PCI? Presenter: Daniel Chami? July 24, 2013